On June 21, 2016 Jesse’s Journey held a special media announcement at the Best Western Plus Lamplighter Inn & Conference Centre, to release details of our 2016 research funding.
Three new research projects have been approved by the Board of Directors for new and existing research projects in 2016 totalling more than $1 million. The new research includes projects in Quebec, Toronto and Ottawa with continued funding supporting researchers in Calgary, the U.S. and the U.K.
With this funding announcement, Jesse’s Journey will have granted Duchenne researchers internationally more than $8 million in the past 21 years.
“The strong support from Jesse’s Journey has been essential in allowing us to move forward with these important studies,” said Dr. Bernard Jasmin, Vice-Dean of Research at the University of Ottawa. “I am delighted to be able to count once again on that support, as we come even closer to designing novel therapeutic approaches for DMD.” Dr. Jasmin attended the announcement to share highlights of his research with utrophin – a protein which could compensate for the lack of dystrophin in Duchenne patients.
Jesse’s Journey founder John Davidson was joined by special student guests Eric Morden and Dylan King, in presenting the 2016 research funding cheque on behalf of Jesse’s Journey. Click here to see photos from this event.
Please see video of the event below, courtesy of Streaming Inc.